Patent · US Active

2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

US7732493B2 · kind B2 · utility

0Cited by

3References

13Claims

0Family size

Assignee

Bayer Schering Pharma AG · DE

Inventors

Alexander Hillisch · Solingen, DE
Olaf Peters · Bad Tabarz, DE
Christian Gege · Ehingen (Donau), DE
Wilko Regenhardt · Munich, DE
Gabriele Moeller · Munich, DE
Dominga Deluca · San Giovanni Lupatoto, IT
Jerzy Adamski · Munich, DE
Walter Elger · Berlin, DE
Birgitt Schneider · Jena, DE

Key dates

Filing date	Aug 15, 2008
Grant date	Jun 8, 2010
Priority date	—
Expiry date	Aug 15, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J63/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to new 2-substituted D-homo-estra-1,3,5(10)-trienes of general formula Iin which

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.